Effects of EXercise TRAining in Sarcoidosis

M. A. Spruit, M. J. Thomeer, R. Gosselink, E. Derom, M. G. Demedts, M. Decramer (Leuven, Ghent, Belgium)

Source: Annual Congress 2005 - Muscle training and chronic lung disease
Session: Muscle training and chronic lung disease
Session type: Oral Presentation
Number: 2781
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. A. Spruit, M. J. Thomeer, R. Gosselink, E. Derom, M. G. Demedts, M. Decramer (Leuven, Ghent, Belgium). Effects of EXercise TRAining in Sarcoidosis. Eur Respir J 2005; 26: Suppl. 49, 2781

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




Effects of Infliximab on FDG Uptake and Small Fiber Neuropathy Symptoms in Sarcoidosis Patients
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021



Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

Genetic Profiles of Clinical Features in Sarcoidosis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018

A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018



Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019


Effects of Ground-Based Walking Training in Pulmonary Hypertension
Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Year: 2020




The Value of Voluntary Cough Sounds for Diagnosis of Pulmonary Disease
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018



O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Unusual Presentation of a Systemic Disease: A Case Report
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019


Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019